Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 700 participants.
Also called NCT07445737
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 700 participants
- Registry
-
NCT07445737 -
2025-523349-86-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07445737. Randomized; no masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
- Acronym
- MAMI
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- Methoxyflurane
- Intervention (Drug)
- Morphine
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Medical Developments International Limited
Record details
- Record id
cardio:ct-nct07445737- Content hash
1b302a76f8396fad7e97c98bf40ba4961e03624303c5fa084aad31522fffba63